WHO recommends new treatment for severe covid cases

The World Health Organization (WHO) today recommended treatment with interleukin-6 antagonists for the treatment of severe or critical cases of Covid-19, after publishing positive results of trials with 11,000 patients.

Until now, the WHO only recommended a treatment for seriously ill patients with dexamethasone, a corticosteroid, but the publication of the trials in the Journal of the American Medical Association has encouraged the WHO to include this new tool against coronavirus.

The tests show that treatment with interleukin-6, a glycoprotein secreted by certain cells, reduces the risk of death by around 4% (17% in ventilated patients).

In addition, in patients who do not yet need ventilation, it reduces the risk of using it by 21%, compared to the usual use of corticosteroids.


See also  China torn between its climate commitments and its dependence on coal